Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

18.41
Delayed Data
As of Aug 28
 +0.37 / +2.05%
Today’s Change
7.51
Today|||52-Week Range
25.25
+90.78%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Kelley Kenneth J
Director
Sale3/05/201540,000$15.33$613.2K+19.62%
Torley Helen I
President & Chief Executive Officer
Buy9/16/201450,000$8.92$446.0K+103.65%
Kelley Kenneth J
Director
Sale6/18/201520,000$21.00$420.0K-13.85%
Ramsay David A
Chief Financial Officer & Vice President
Buy9/16/201425,000$8.90$222.5K+103.65%
Stelzer Laurie
Chief Financial Officer
Buy8/20/201510,000$17.24$172.4K+7.16%
Stelzer Laurie
Chief Financial Officer
Buy8/20/201510,000$17.24$172.4K+7.16%
Torley Helen I
President & Chief Executive Officer
Sale1/06/201511,919$10.06$119.9K+83.00%
Ramsay David A
Chief Financial Officer & Vice President
Buy9/16/201450,000$2.05$102.5K+103.65%
Ramsay David A
Chief Financial Officer & Vice President
Sale12/22/20146,621$9.46$62.6K+97.32%
Kelley Kenneth J
Director
Buy6/05/201510,000$4.94$49.4K-7.81%
Page of 3